This systematic review and meta-analysis found that radiation, chemotherapy, and their combination were associated with an increased risk of secondary malignancies after treatment of testicular germ cell tumors, while surgery alone was not. @moosemousa

Chemotherapy, radiation, and their combination increase the risk of non-germ cell secondary malignancies after testicular cancer treatment. Our systematic review & meta-analysis out now in @JNCI_Now. @RHamiltonUrol https://t.co/tyLjRb5BVm

This population-based assessment in Ontario, Canada revealed that only 11.9% of patients w/ #ProstateCancer on ADT received all recommended testing to screen for adverse effects associated with treatment. https://t.co/E5kWEO7yCG @moosemousa @OncoAlert #GU25

As therapies evolve and men with advanced prostate cancer live longer, screening for adverse effects associated with androgen deprivation should become a priority. Our study in Cancer revealing low rates of testing across the board. @WallisCJD @ICESOntario

Most pts with pathologic stage II testicular non-seminomatous germ cell tumors treated with #primaryRPLND only won't experience relapse or need chemo. Altho #adjuvantchemotherapy may reduce relapse risk, disease specific survival is unchanged #testescancer https://t.co/B8Te5dMids

Minimizing the use of chemotherapy following pRPLND, the @pmcancercentre experience: https://t.co/uBScepG4Qh @RHamiltonUrol

Check out our latest publication comparing open vs. robo RPLND. Our findings suggest R-RPLND is associated with: 🔹Shorter LOS (1 vs. 5 days) 🔹Lower EBL (200ml) 🔹Comparable relapse and complication rates @RHamiltonUrol @EurUrolOncol https://t.co/76zuJY44NG

Thrilled to have matched to the Toronto SUO Oncology fellowship! The opportunity to continue learning from invaluable mentors in a city that I love, alongside people that I love is a blessing @UofTUrology @UroOnc @SUO_YUO

Big paper out in @TheLancetOncol from my partner Alex Zlotta highlighting data for TMT in #mibc https://t.co/4Lm30WJVAs @UofTUrology @UofTSurgery @SinaiHealth

Feel privileged to present our meta-analysis of clinical studies comparing TFL vs Ho:YAG lasers for lithotripsy at #AUA23. Thanks to Dr. Chua, @ArmandoJLorenzo and @JYLeeUro for their mentorship and the opportunity! Check out our manuscript here: https://t.co/sbA6jHXYCr

Thanks to @RHamiltonUrol for his mentorship, paper coming soon. More evidence to support a reduction in the use of adjuvant chemotherapy following pRPLND for PSII disease. Poster here:

Canadian Urology residents take on @UroOnc @SUO_YUO meeting in San Diego 🇨🇦🇨🇦

Could statins improve survival in men with advanced PC? Our meta-analysis suggests a consistent protective OS and CCS signal in ~120,000 pts Statins are cheap, safe, and have an established CVD benefit. Time for an RCT! @RHamiltonUrol @KlotzLaurence @FleshnerNeil @UofTUrology

Unfortunate case with fortunate outcome! Just published: replantation for penile glans amputation during neonatal circumcision @ArmandoJLorenzo

limited health care resource remains to be a significant bottle neck that we are (somehow) no better prepared to face two years into the pandemic.... as the waitlists grow many more of our patients will suffer

Who wrote this incredible “paper”? Your Public Health Service will not go unnoticed 😂

An opportunity for students to hear about the @UofTUrology program, to meet our selection committee and talk with some of our amazing residents!

Best cameo ! Thanks for taking the time to send well wishes to all our residents ... amazing !

I made a 2020 commemorative candle